sb 203580 has been researched along with dynorphins in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (dynorphins) | Trials (dynorphins) | Recent Studies (post-2010) (dynorphins) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 3,096 | 24 | 514 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Hasani, R; Bloodgood, DW; Bruchas, MR; Crowley, NA; Hardaway, JA; Kash, TL; Kendra, AM; Krashes, MJ; Lowell, BB; McCall, JG; McCall, NM; Schools, ZL; Whistler, JL; Yu, W | 1 |
1 other study(ies) available for sb 203580 and dynorphins
Article | Year |
---|---|
Dynorphin Controls the Gain of an Amygdalar Anxiety Circuit.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Amygdala; Animals; Anxiety; Behavior, Animal; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Channelrhodopsins; Dynorphins; Evoked Potentials; Glutamic Acid; Imidazoles; Male; Maze Learning; Memory; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Microscopy, Fluorescence; p38 Mitogen-Activated Protein Kinases; Patch-Clamp Techniques; Pyridines; Receptors, Opioid, kappa; Septal Nuclei | 2016 |